Genetic studies may help physicians identify bladder cancer patients who are at increased risk of cancer recurrence, suggests new research. While patients with variants in the aldehyde dehydrogenase 2 (ALDH2) gene and the vascular cellular adhesion molecule 1 (VCAM1) gene suffered fast recurrence, the ones with non-invasive tumors and a variant in the DNA repair gene XRCC4 tended to live long. The revelation will probably facilitate identification of patients who require ...
via Medindia Health News
More READ
No comments:
Post a Comment